RGEN

$125.61+7.40 (+6.26%)

Pre-Market$127.90+2.29 (+1.82%)· Last close May 5

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO